MECICS Obtains US FDA Approval for Mechanical Ventilator
[Asia Economy Reporter Geum Bo-ryeong] Mcare ICS announced on the 8th that it has obtained approval from the U.S. Food and Drug Administration (FDA) for its ventilator 'MTV1000'.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Given Grants, Then Says "No Launch" ... Innovative Korean Technology Ultimately Forced Overseas
- [Breaking] Chairman Park Sookeun: "Possibility of Agreement Instead of Samsung Electronics Labor-Management Mediation Proposal"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Mcare ICS explained, "The expected effect is to assist the breathing of patients with respiratory distress and improve respiratory failure through continuous or intermittent mechanical ventilation. It supplies warmed and humidified high-flow oxygen to patients suffering from hypoxia due to lung disease, increasing functional residual capacity and reducing anatomical dead space, thereby improving pulmonary oxygenation."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.